Artificial intelligence is increasingly used in consumer healthcare to manage personal data and support health-related decisions. Use cases range from administrative tasks, such as appointment scheduling and note-taking, to handling basic health queries. As these tools become more accessible, industry participants are encouraging broader use beyond routine functions.

AI As A Personal Health Advisor

The development of AI tools is extending into everyday health support. Alex Zhavoronkov, CEO of Insilico Medicine, said consumers can use AI systems to address routine health-related questions. Speaking at CNBC’s CONVERGE LIVE event in Singapore, he noted that some AI tools are capable of handling basic inquiries, allowing medical professionals to focus on more complex cases.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Major Tech Players Enter The Health Arena

At the same time, large technology companies are expanding into consumer health applications. OpenAI introduced ChatGPT Health, a platform that connects medical records and wellness applications to an AI interface. Similarly, Amazon launched HealthAI for users of One Medical, offering analysis of medical records, laboratory results, and current medications.

Balancing Innovation And Caution

As adoption increases, industry representatives are highlighting the need for oversight. Shreehas Tambe, CEO and Managing Director of Biocon, said that reliance on advanced systems without sufficient familiarity may introduce risks. He added that expert review remains necessary, particularly in areas such as drug development and clinical validation.

Revolutionizing Drug Discovery

Beyond consumer applications, AI is also reshaping pharmaceutical research. Development timelines for drug candidates can be reduced from more than four years to around 18 months. This shift is reflected in a $2.75 billion collaboration between Eli Lilly and Insilico Medicine, highlighting continued investment in AI-driven drug discovery.